Botox | Dysport 1:3 | Dysport 1:4 | |
---|---|---|---|
*See table 2 for explanation; †Dysport 1:3 v Botox, p=0.06; ‡Dysport 1:4 v Botox, p=0.03; §Dysport 1:3 v Botox, p=0.01; ¶Dysport 1:4 v Botox, p<0.01. | |||
Number of injections* | n=51 | n=51 | n=52 |
Number of patients with adverse events | 9 (17.6%) | 17† (33%) | 19‡ (36%) |
Number of adverse events | 10 | 22§ | 27¶ |
Type of adverse events: | |||
Dysphagia | 2 (3%) | 8 (15.6%) | 9 (17.3%) |
Dysphonia | 0 | 3 | 3 |
Asthenia | 2 | 2 | 7 |
Neck weakness | 2 | 3 | 2 |
Prolonged pain at injection point | 2 | 3 | 3 |
Dry mouth | 0 | 2 | 1 |
Others | 2 | 1 | 2 |